Why the DEA STRIDE Data are Still Useful for Understanding Drug Markets
NBER Working Paper No. 14224
---- Acknowledgements -----
This research was supported by a grant from the National Institute on Drug Abuse (1R01 DA019993). The authors thank Martin Iguchi, Don Kenkel, Beau Kilmer, Jeanne Ringel and members of the National Academy of Sciences and Engineering, Committee on Law and Justice for their insightful comments. They also thank Terry Zoebeck, Mike Cala, Richard Meyers, and Jeffry Comparin for their assistance understanding the STRIDE data, its fields, and the data entry process. The views expressed herein are those of the author(s) and do not necessarily reflect the views of the National Bureau of Economic Research.